Macleods Pharmaceuticals Limited (Macleods) has received FDA approval for the ANDA for DAPSONE, ensuring continued access to this essential medication for treating leprosy. The approval is critical for expanding availability amidst fluctuations in the global supply chain, reinforcing Macleods’ position as a stable supplier for this critical antiparasitic agent.